Drug Research
Valneva Signs Purchase Agreement with European Commission for its Inactivated COVID-19 Vaccine VLA2001
Valneva SE, a specialty vaccine company, today announced that it has signed an Advance Purchase Agreement (APA) with the European Commission (EC) to supply up to 60 million doses of its inactivated COVID-19 vaccine candidate, VLA2001, over two years....
Drug Research
Sanofi invests $180 million equity in Owkin’s artificial intelligence and federated learning to advance oncology pipeline
Sanofi announced an equity investment of $180 million and a new strategic collaboration with Owkin comprised of discovery and development programmes in four exclusive types of cancer, with a total payment of $90 million for three years plus additional...
Drug Research
Twist Bioscience Launches Revelar Biotherapeutics to Develop and Commercialize Novel COVID-19 and Other Antibody Therapeutics
Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, announced it has launched Revelar Biotherapeutics, Inc., an independently operated, new biotechnology company to develop and commercialize an antibody,...
Drug Research
uMotif collaborates with The University of Manchester on body mapping tool to accelerate pain reporting for people living with musculoskeletal conditions
uMotif, a leading eClinical platform provider powering patient-centric research, has joined up with researchers at The University of Manchester to investigate the real-world usability of its digital body mapping tool in a feasibility study in people living with musculoskeletal...
Drug Research
Swiss CDMO Invests in Powder Containment and Extends Spray Drying Capabilities
Micro-Sphere has added to its contract development and manufacturing expertise with new spray drying technology and increased high containment capabilities.
The Swiss contract development and manufacturing organisation (CDMO), which specialises in spray drying and capsule filling, has invested more than...
Drug Research
Aragen expects to ride wave of US biotech growth in 2022 – influx of discovery capital is surging demand for CDMO services
Aragen Life Sciences (formerly, GVK BIO), a leading partner offering R&D and Manufacturing solutions (CRO/CDMO) for life sciences industries worldwide, expects high teens growth in 2022, with NCE development and manufacturing business growing at circa 40% year-on-year.
The company, states...
Drug Research
AbbVie, University of Chicago Extend Research Collaboration to Support Preclinical Oncology Research Through 2025
AbbVie and the University of Chicago and have extended their collaboration agreement through 2025 to support preclinical oncology research.
To date, the collaboration has led to novel insights related to biomarkers and therapeutic applications for existing AbbVie programs. This has...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
